White Matter Structural Alternations in Children with HIV Infection and Exposure
Marcin Jankiewicz1, Paul A. Taylor1,2,3, Martha Holmes1, Mark F. Cotton4, Barbara Laughton4, Andre J.W. van der Kouwe5, and Ernesta M. Meintjes1

1MRC/UCT Medical Imaging Research Unit, Department of Human Biology, University of Cape Town, Cape Town, South Africa, 2Scientific and Statistical Computing Core, National Institutes of Health, Bethesda, MD, United States, 3African Institute for Mathematical Sciences, Muizenberg, South Africa, 4Children’s Infectious Diseases Clinical Research Unit, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa, 5Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States

Synopsis

In this work we examine WM alterations in HIV infected children at age 7 years and compare those who initiated ART before and after 12 weeks of age.

INTRODUCTION

While previous studies have consistently shown HIV-related white matter (WM) microstructural alterations in adults, adolescents, children and animal models, studies in youth have typically included wide age ranges during which both white matter volume and FA increase significantly [1-5]. There are no studies examining whether early ART (before 12 weeks of age) could mitigate these effects. Here we examine WM alterations in HIV infected children at age 7 years and compare those who initiated ART before and after 12 weeks of age.

METHODS

POPULATION: One hundred and twenty-one (Xhosa and Cape Coloured) 7-year-old children from a longitudinal neurodevelopmental sub study of the Children with HIV Early Antiretroviral (CHER) trial [6] in Cape Town, South Africa were studied. The group included HIV-infected children, stable on antiretroviral therapy (ART) and age-matched controls from a parallel vaccine study [7]. After exclusion of subjects due to motion artifacts we divided our subjects into the following groups for comparison: controls (CTRL, 48 children, age 7.24±0.13 yrs (mean age ± standard deviation), 26 males, 39 Xhosa) and HIV infected (HIV, 68, 7.21±0.13 yrs, 33 males, 59 Xhosa). Within controls there were HIV-exposed, uninfected (HEU) (19 children, age 7.22±0.11 yrs, 11 males, 10 Xhosa) and HIV-unexposed, uninfected (HUU) (29 children, age 7.25±0.15 yrs, 15 males, all Xhosa) children. The HIV group was also divided into two treatment subgroups: children who initiated ART at or before 12 weeks of age (EARLY, 53 children, age 7.21±0.10 yrs, 25 males, 46 Xhosa) and those who began ART treatment after 12 weeks (LATE, 15 children, age 7.17±0.20 yrs, 8 males, 13 Xhosa).

SCANNING PROCEDURE: Children in the study were scanned on a 3T Siemens Allegra (Erlangen, Germany) with a single channel head coil according to protocols that had been approved by the Human Research Ethics Committees of participating institutions. Children were scanned with structural T1 imaging followed by 2 DTI acquisitions with opposite phase encoding (AP-PA) directions using a prospectively motion-corrected navigated twice-refocused spin echo sequence with 5 reacquisitions [8]. Acquisition parameters for diffusion were: TR/TE 10100/86ms, 72 slices, 2×2×2mm3, FOV 224mm, 30 non-collinear diffusion directions, b=1000s/mm2, and four non-diffusion-weighted (b0) acquisitions.

DIFFUSION DATA PROCESSING: DTI data were preprocessed in TORTOISE [9]: for each subject the set of AP-PA phase-encoded data sets was corrected for motion and eddy current distortions. FSL and AFNI were used to co-register all of the DTI results to the Haskins pediatric template [10]. Voxel-wise group comparisons were performed in FSL [11] based on a general-linear model (gender and race included as confounders). Clusters showing statistical group differences were identified from uncorrected p-value maps for 3 sets of group comparisons (CTRL vs HIV; HEU vs HUU; EARLY vs LATE). Cluster size thresholding at pth=0.005 and alpha=0.05 (where alpha is the probability of random noise at pth) yielded a minimum cluster size of 102mm3 for CTRL vs HIV, and 110mm3 for HEU vs HUU and EARLY vs LATE comparisons.

RESULTS

One region (in left (L) inferior longitudinal fasciculus) showed lower FA and 5 regions (in right (R) corticospinal tract, bilateral inferior fronto-occipital fasciculus, R superior longitudinal fasciculus, and R superior fronto-occipital fasciculus) higher MD in infected children compared to controls (Figures 1 and 2). Three regions were identified in 2 tracts (bilateral corticopontine tract and middle cerebellar peduncle) with higher FA in HEU children compared to HUU children, and bilateral regions in the superior longitudinal fasciculus showed lower MD in HEU children (Figures 3 and 4). No regions showed FA or MD differences between children in EARLY and LATE groups.

DISCUSSION and CONCLUSIONS

CTRL vs HIV: Lower FA and higher MD in HIV-infected children were largely attributable to higher radial diffusivity (L23), indicative of poorer myelination in the affected regions. Regions with increased MD also showed increased axial diffusivity (L1). Both axial and radial diffusivity have been shown to decrease from neonates to 1-year olds [12] and throughout childhood [13]. The higher levels in HIV-infected children seen here could be indicative of altered developmental trajectories.

HEU vs HUU: Unexpectedly, we only found regions showing higher FA in HEU children compared to HUU children. These effects were attributable both to higher L1 and lower L23, suggesting improved myelination in these children. Moreover, lower MD in the superior longitudinal fasciculus in HEU children was due to reduced L1 and L23.

EARLY and LATE: The absence of differences between these groups may be due to the small sample size of the latter.

Acknowledgements

Support for this study was provided by NRF/DST South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network, Grant U19 AI53217; NIH grants R01HD071664 and R21MH096559; NRF grant CPR20110614000019421, and the Medical Research Council (MRC). We thank the CUBIC radiographers (Marie-Louise de Villiers, Nailah Maroof and Alison Siljeur), our research staff (Thandiwe Hamana and Rosy Khethelo), and Shabir A. Madhi for access to control participants on the CIPRA-SA04 trial.

References

[1] Filippi M., et al., Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group. J Magn Reson Imaging, 15(5): p. 499-504, 2002.

[2] Barnea-Goraly et al., White matter development during childhood and adolescence, Cerebral Cortex, 2005

[3] Giedd et al., Brain development during childhood and adolescence: a longitudinal MRI study, Nature Neuroscience, 1999

[4] Brouwer et al., White Matter Development in Early Puberty: A Longitudinal Volumetric and Diffusion Tensor Imaging Twin Study, PLOS one, 2012

[5] Lentz et al., Diffusion tensor and volumetric magnetic resonance measures as biomarkers of brain damage in a small animal model of HIV, PLoS One, 2014

[6] Cotton MF, Violari A, Otwombe K, et al., Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: Results from the children with HIV early antiretroviral (CHER) randomized trial, Lancet, 382: 1555–63, 2013

[7] Madhi S, Adrian P, Cotton M, et al., Effect of HIV infection status and anti retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants, JID 202(3):355-61, 2012

[8] Alhamud et al., Volumetric navigators for real-time motion correction in diffusion tensor imaging, MRM, 68(4):1097-108, 2012

[9] Pierpaoli C, Walker L, Irfanoglu MO, Barnett A, Basser P, Chang L-C, Koay C, Pajevic S, Rohde G, Sarlls J, Wu M. 2010. TORTOISE: An Integrated Software Package for Processing of Diffusion MRI Data. ISMRM 18th Annual Meeting, Stockholm, Sweden, p. 1597

[10] Molfese PJ, Glen D, Mesite L, Pugh K, Cox RW (2015): The Haskins pediatric brain atlas. 21st Annual Meeting of the Organization for Human Brain Mapping (OHBM)

[11] Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. NeuroImage, 92:381-397, 2014

[12] Gao et al., Temporal and Spatial Development of Axonal Maturation and Myelination of White Matter in the Developing Brain, Am J Neuroradiol 30:290–96, 2009

[13] Kumar R et al., Regional brain axial and radial diffusivity changes during development, J Neurosci Res. 90(2):346-55, 2012

Figures

Figure 1: Peak intensity coordinates/positions of clusters with significant group differences between CTRL and HIV groups. Cluster in ilf (L) tract had lower FA values in HIV-infected children. Clusters (in cst (R), ifo (L) and (R), slf (R) and sfo (R) tracts) had significantly higher MD values in children with HIV.

Figure 2: Boxplots comparing fractional anisotropy (FA) and mean diffusivity (MD) between CTRL and HIV children in regions identified in Figure 1, as well as axial (L1) and radial (L23) diffusivity in each of these clusters. Units of MD, L1, and L23 are 10-3mm2s-1. Significance of t-tests between the groups are shown in the upper right corner of each boxplot.

Figure 3: Peak intensity coordinates/positions of clusters showing group differences between HEU and HUU groups. Clusters in cpt (R) and (L) and mcp (R) had higher FA in HEU children; two clusters in slf (R) and (L) had lower MD in HEU children.

Figure 4: Box plots showing differences in FA and MD between HEU and HUU groups. Additionally, the values of corresponding axial (L1) and radial (L23) diffusivity are shown for each of the clusters. Units of MD, L1, and L23 are 10-3mm2s-1. Significance of t-tests between the groups are shown in the upper right corner of each boxplot).



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
4417